Optimal Design for Nonlinear Response Models

Regular price €192.20
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
A01=Sergei L. Leonov
A01=Valerii V. Fedorov
advanced experimental design strategies
Age Group_Uncategorized
Age Group_Uncategorized
Author_Sergei L. Leonov
Author_Valerii V. Fedorov
automatic-update
Bayesian inference
biostatistics
Category1=Non-Fiction
Category=GPS
Category=MBGR1
Category=PBT
Category=PS
Category=TDCW
clinical trial optimization
COP=United States
Delivery_Delivery within 10-20 working days
eq_isMigrated=0
eq_isMigrated=2
eq_nobargain
experimental methodology
Language_English
PA=Available
pharmacokinetic modeling
Price_€100 and above
PS=Active
softlaunch
statistical learning methods

Product details

  • ISBN 9781439821510
  • Weight: 742g
  • Dimensions: 156 x 234mm
  • Publication Date: 15 Jul 2013
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: US
  • Product Form: Hardback
  • Language: English
Secure checkout Fast Shipping Easy returns

Optimal Design for Nonlinear Response Models discusses the theory and applications of model-based experimental design with a strong emphasis on biopharmaceutical studies. The book draws on the authors’ many years of experience in academia and the pharmaceutical industry.

While the focus is on nonlinear models, the book begins with an explanation of the key ideas, using linear models as examples. Applying the linearization in the parameter space, it then covers nonlinear models and locally optimal designs as well as minimax, optimal on average, and Bayesian designs. The authors also discuss adaptive designs, focusing on procedures with non-informative stopping.

The common goals of experimental design—such as reducing costs, supporting efficient decision making, and gaining maximum information under various constraints—are often the same across diverse applied areas. Ethical and regulatory aspects play a much more prominent role in biological, medical, and pharmaceutical research. The authors address all of these issues through many examples in the book.

Valerii Fedorov, PhD, is Vice President of Predictive Analytics, Innovation at Quintiles.

Sergei Leonov, PhD, is a Senior Principal Scientist at AstraZeneca.

More from this author